Carl L. McMillian
Carl L. McMillian is vice-president, Toxicology, Drug Disposition, PK/PD, Eli Lilly and Company.
Articles
Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation
Margaret M. Faul;Carl L. McMillian ;Pierre Boulas;Reginaldo A. Saraceno;Mary Devlin Capizzi;Maureen T. Cruz
October 15th 2020The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: December 9th 2024 | Updated: December 24th 2024
Recap Key Industry Trends for Viral Clearance and NGS
Published: December 7th 2024 | Updated: December 24th 2024
Enhancing Quality Through Training
Published: July 20th 2020 | Updated: December 24th 2024
Contact BioPharm International Editors
Published: July 19th 2020 | Updated: December 24th 2024
Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars
